Xyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotein e deficient mice.

Mar Drugs · 2015 · PMC4413213 · PMID 25874925

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

While the pD 2 of Ach in xyl-B treated apoE −/− mice (−7.12 ± 0.04) tended to increase, it did not reach statistical significance as that in the Simvastatin group (−7.38 ± 0.04) in comparison to apoE −/− mice (−6.94 ± 0.02).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.